Efficacy and safety of selpercatinib in patients with RET-altered thyroid cancers: Update of the phase 1/2 study (LIBRETTO-001)
Makoto Tahara, Shinji Takeuchi, Kadoaki Ohashi, Yoshitaka Honma, Tomoya Yokota, Tsutomu Iwasa, Joji Mori, Yukie Omori, Yasushi Shimizu
Author information
Keywords:
thyroid cancer,
medullary thyroid cancer,
molecular targeted therapy,
selpercatinib,
RET gene
2024 Volume 41 Issue 4 Pages 292-300
Details
